Entries by aaron

Pfizer Marstacimab regulatory submissions for treatment of Hemophilia A and B accepted by USFDA, EMA

New York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) for its anti-tissue factor pathway inhibitor (anti-TFPI) candidate marstacimab for individuals living with hemophilia A or hemophilia B without inhibitors to Factor VIII (FVIII) or Factor IX (FIX). The European marketing authorization application (MAA) for […]

Are intracavernosal injections of platelet-rich plasma effective against erectile dysfunction?

Italy: Platelet-rich plasma (PRP) intracavernosal injections may objectively improve or at least show a tendency for recovery in erectile function in men affected by primary organic erectile dysfunction (ED), a recent meta-analysis has revealed. The findings were published online in the International Journal of Impotence Research on November 22 2023. “The generalizability of these observations […]

Which are most effective medications for migraine?

USA: Selected acute medications (e.g., ergots, anti-emetics, triptans) are associated with higher odds of user-rated positive response versus ibuprofen for patients with migraine, a recent study published in Neurology has shown. Using a big-data approach, the researchers analyzed patient-generated real-time records of 10 million migraine attacks, and simultaneous head-to-head comparisons of 25 acute migraine medications […]

Vitamin D Deficiency Linked to Higher Risk of Noninfectious Uveitis

A recent systematic review and meta-analysis exploring the relationship between vitamin D levels and noninfectious uveitis have revealed a striking association. The findings suggest that individuals with vitamin D deficiency face more than a twofold increased risk of developing noninfectious uveitis compared to those without such deficiency. This study was published in the Autoimmunity Reviews […]

Cell therapy appears safe and effective for lymphoma in remission

A study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins. While the study doesn’t answer the question of whether cell therapy in remission is […]

Metabolic syndrome in women associated with carotid artery thickness regardless of obesity

A recent investigation examined the combined influence of metabolic syndrome (MetS) and obesity on markers of early atherosclerosis—carotid artery intima media thickness (cIMT) and adventitial diameter (AD). This study was published in the Menopause journal by Leis and colleagues. Carotid ultrasound assessments conducted as part of the Study of Women’s Health Across the Nation (SWAN) […]

AstraZeneca gets a CDSCO panel Nod To study Rilvegostomig

New Delhi: The drug major AstraZeneca has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the trial of the Rilvegostomig (AZD2936) concentrate for solution for infusion to assess the efficacy and tolerability of rilvegostomig compared to placebo in combination with investigator’s choice of chemotherapy […]

Haryana doctors threaten indefinite strike from December 29

The day following a two-hour pen-down strike at government health facilities, Haryana Health Department’s medical professionals announced on Sunday their intention to launch an indefinite strike from December 29 if their demands remained unmet within two weeks. This decision was reached during the core committee meeting of the Haryana Civil Medical Services Association (HCMSA), the […]